Drop attacks induced by hypothyroidism.

U Kramer; A Achiron

doi:10.1111/j.1600-0404.1993.tb05369.x

Home/Archive/PubMed

PubMed · 8116341

Drop attacks induced by hypothyroidism.

U Kramer·A Achiron

View original source ↗Export metadata ↓

Abstract

Drop attacks (DA) are defined as sudden repeated falls without warning and without loss of consciousness. A variety of etiologies are known to be responsible for symptomatic DA, but the reason for idiopathic DA remains obscure. A 70-year-old woman who suffered from classic DA over a period of a year is described. The diagnostic work-up revealed severe myxedema. Treatment with eltroxin resulted in complete clinical and endocrine recovery and disappearance of DA while with discontinuation of hormone replacement therapy, DA reappeared. Thus, a direct relationship between hypothyroidism and DA can be considered.

Explore related subjects

Accidental Falls Aged Estrogen Replacement Therapy Female Humans Hypothyroidism Myxedema Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

U Kramer, A Achiron. 1993. Drop attacks induced by hypothyroidism.. https://doi.org/10.1111/j.1600-0404.1993.tb05369.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2008

Fulminant pulmonary embolism treated by extracorporeal membrane oxygenation in a patient with traumatic brain injury.

Explore the source record for details and available documents.

Accidental Falls↗

PubMed2007

Escitalopram in the long-term treatment of major depressive disorder in elderly patients.

AIM: The primary aim was to investigate the long-term safety and tolerability of escitalopram (10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The secondary aim was to examine response to treatment, as measured by change in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from study entry to each visit, using observed cases. METHOD: This extension trial included 225 patients who had completed an 8-week, double blind, placebo-controlled lead-in study, which was performed in outpatients in primary care and in specialist clinics. The intent-to-treat population comprised 223 patients. RESULTS: The overall withdrawal rate was 24%. The most common reason for withdrawal was adverse events (9%). The 5 most common adverse events were accidental injury, rhinitis, weight increase, arthralgia and coughing, with an incidence ranging from 8 to 13%. No new types of adverse events were reported in this extension study compared to the 8-week lead-in study. The mean weight increased from 69.7 kg at study entry to 70.3 kg at endpoint. The percentage of patients in remission (MADRS total score < or = 12) increased from 48% at study entry to 72% by week 52. CONCLUSION: Escitalopram demonstrated a favourable tolerability profile during 52 weeks of open-label treatment of elderly patients, with further improvement in depressive symptoms.

Accidental Falls↗

PubMed2007

MRI of rupture of the spring ligament complex with talo-cuboid impaction.

The spring ligament complex is essential for the stability of the longitudinal arch of the foot and includes the ligaments between the calcaneus and the talus at the superomedial to inferoplantar aspect of the foot. Tears of the spring ligament complex are most commonly degenerative in etiology and secondary to concomitant abnormality of the posterior tibial tendon. We report MRI findings in a 30-year-old man who presented with traumatic rupture of the spring ligament complex, seen following dislocation of the talonavicular joint. We also describe the previously unreported MRI features of talo-cuboid impaction secondary to disruption of the spring ligament complex.

Accidental Falls↗